Scholarship, Pepperdine University, and the Legacy of Churches of Christ

We hope that this small book will help Pepperdine faculty and staff members understand more about the specific Christian tradition to which Pepperdine is related-the Churches of Christ-and how that tradition can fruitfully interact with and even sustain the task of Christian higher education in the context of this institution.https://digitalcommons.pepperdine.edu/cfl_pubs/1000/thumbnail.jp

The long-acting somatostatin analogue octreotide alleviates symptoms by reducing posttranslational conversion of prepro-glucagon to glucagon in a patient with malignant glucagonoma, but does not prevent tumor growth

A 52-year-old female with metastatic glucagonoma secreting glucagon and chromogranin A was treated with the somatostatin analogue octreotide for 2 years without any additional tumor-reducing interventions. Before therapy plasma glucagon was above 8 μg/l (normal <0.2) and within 2 days 3 × 200 μg octreotide daily suppressed plasma glucagon to 2.2-2.5 μg/l. Concomitantly, chromogranin A dropped from 0.85 mg/l (normal <0.1) to 0.2. After 3 weeks the preexisting disabling necrolytic migratory erythema had vanished completely, and weight loss was temporarily stopped. During therapy chromogranin A and plasma glucagon rose, exceeding pretreatment levels after 3 and 14 months, respectively. After 1 year the erythema recurred, responding only transiently to increasing doses of octreotide. The patient died after 2 years of therapy of tumor cachexy despite very highdosesof octreotide (4 × 600 μg/day). Throughout treatment octreotide did not prevent tumor growth, as demonstrated by computed tomography and sonography. Determination of immunoreactive glucagon before and during octreotide therapy in fractions of plasma samples subjected to gel chromatography revealed a reduction in the ratio of glucagon to preproglucagon from 1.83 (before) to 0.56 (during therapy), indicating inhibition of posttranslational processing of preproglucagon by octreotide, thereby reducing circulating bioactive glucagon. In summary, octreotide induced a remission of clinical symptoms by inhibiting posttranslational conversion of preproglucagon to glucagon but did not prevent tumor growth. Therefore, octreotide is a valuable therapy for rapid relief of clinical symptoms, thereby improving the possibilities for other tumor-reducing therapies

A Tale of Two Tantalum Borides as Potential Saturable Absorbers for Q-Switched Fiber Lasers

In this paper, we analyze the performance of two tantalum-based boride (TaB and TaB 2 ) microparticles as potential saturable absorbers for high-power fiber lasers. Both materials are ultrahigh temperature ceramics with melting points above 3000 °C, but with different crystalline structures: TaB has an orthorhombic structure (nearly isotropic), whereas TaB 2 has a hexagonal structure (uniaxial, anisotropic). Despite their different crystalline structures, the microparticles have a similar low fluence attenuation (between 2.3 and 2.60 dB/μm) and modulation depths (around 2.0 dB/μm), but remarkable different saturation fluences: TaB has a saturation fluence of 160 μJ/cm 2 , whereas TaB 2 has a saturation fluence of 110 μJ/cm 2 . The measured damage thresholds are 112 and 10 6 mJ/cm 2 /pulse for TaB and TaB 2 , respectively. When incorporated to a fiber laser, the materials produce pulses with durations of 345 ns, lower than those reported by our group in previous papers. The results show that the materials can find potential applications in high-power Q-switched lasers

Lectures in Honor of the Alexander Campbell Bicentennial

In 1984, the Disciples of Christ Historical Society set forth a program to celebrate the 200th birthday of Alexander Campbell. This book launched a renewed interest in Stone-Campbell history and inspired research that shaped numerous historical projects. Contributors include T. Dwight Bozeman, Robert O. Fife, Richard L. Harrison, Samuel S. Hill, Thomas Olbricht, William J. Richardson, D. Newell Williams, Eva Jean Wrather, and Barbara Brown Zickmund.https://digitalcommons.acu.edu/acu_library_books/1018/thumbnail.jp

Interview with Tom Olbricht

The following biographical note is excerpted from The Christian Chronicle: [Dr. Thomas H.] Olbricht, [founder of the Christian Scholars Conference], earned a bachelor’s at Northern Illinois University in 1951, a master’s and doctorate from the University of Iowa, and a theology degree from Harvard Divinity School in 1962. He taught speech at Harding University in Searcy, Ark., and the University of Dubuque, where he also chaired the department. He later taught at Pennsylvania State University before moving to Texas to teach Bible and theology at Abilene Christian University from 1967 to 1986. He also served as dean of ACU’s College of Liberal and Fine Arts for four years. From 1986 to 1996 he taught at Pepperdine University in Malibu, Calif